Chinese lantern clonal line ki1496
AssigneeKemin Industries, Inc.
InventorsBrindha Narasimhamoorthy, John Andrew Greaves, Liuqing Zhao, Zhiqiang Qiu
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to a Chinese lantern plant and, more specifically, to a proprietary clonal plant line KI1496 that contains elevated amounts of zeaxanthin and β-cryptoxanthin.
Claims15
A method of producing zeaxanthin and/or BCX, comprising extracting zeaxanthin and/or BCX from plant tissue of a Chinese lantern plant denominated KI1496 as produced by a plant line deposited with the ATCC and assigned accession number PTA-125794.
A method of providing a carotenoid, comprising extracting zeaxanthin and/or BCX from plant tissue of a Chinese lantern plant denominated KI1496 as produced by a plant line deposited with the ATCC and assigned accession number PTA-125794.
A method of making a carotenoid-containing product, comprising:
- a. growing a Chinese lantern plant denominated KI1496 as produced by a plant line deposited with the ATCC and assigned accession number PTA-125794;
- b. harvesting the mature lanterns;
- c. extracting zeaxanthin and/or BCX from the mature lanterns;
- and
- d. including the extracted zeaxanthin and/or BCX in a carotenoid-containing product.
A method by which the Chinese lantern plant line denominated KI1496 is used in a breeding program by using pollen from said clonal lines as a male parent;
- or flowers of said clonal lines as a female parent, for the generation of seed of a breeding population from which further selections can be made.
A plant or node of the Chinese lantern plant line denominated KI1496, or a cutting or part thereof, wherein representative plant tissue of KI1496 has been deposited with the ATCC and assigned accession number PTA-125794.
Dependencies are inferred from the claim text.